Retrouvez nos résultats orginaux pendant les sessions MICI à l’UEGW 2026 du 17 au 20 octobre 2026 à Barcelone !
Nos présentations :
PHARMACOKINETIC AND IMMUNOGENIC PROFILE OF SUBCUTANEOUS INFLIXIMAB AFTER SWITCHING FROM INTRAVENOUS INFLIXIMAB : A POST HOC ANALYSIS OF THE PEREM COHORT
Lundi 19 octobre | 16:00 – 17:00 | Présentation orale
Xavier Roblin
LYMPHOMA IN INFLAMMATORY BOWEL DISEASE DURING THE BIOLOGIC ERA : A STUDY OF THE I-CARE EUROPEAN PROSPECTIVE COHORT
Lundi 19 octobre | 14:30 – 15:30 | Abstract Session
Julien Kirchgesner
PERSISTENCE, EFFICACY AND TOLERANCE OF SUBCUTANEOUS INFLIXIMAB AFTER SWITCH FROM INTRAVENOUS ROUTE IN IBD PATIENTS IN REMISSION: WEEK 96 RESULTS FROM A FRENCH MULTICENTER PROSPECTIVE COHORT
Mardi 20 octobre | 14:30 – 15:30 | Poster modéré
Marianne Hupé
SIX-MONTHS EFFECTIVENESS AND SAFETY OF UPADACITINIB AFTER FAILURE OF RISANKIZUMAB IN CROHN’S DISEASE: A MULTICENTER REAL-WORLD COHORT STUDY
Mardi 20 octobre | 14:30 – 15:30 | Poster modéré
Nicolas Richard
FILGOTINIB IN PATIENTS WITH REFRACTORY ULCERATIVE PROCTITIS: A MULTICENTRE GETAID STUDY
E-poster
Pauline Wils